• Explore /
  • Poster
  • / Neoadjuvant short-course radiotherapy followed by chemotherapy plus camrelizumab versus long-course chemoradiotherapy followed by chemotherapy for patients with locally advanced rectal cancer: A randomized, multicenter, open-label phase 3 trial (Union).

Neoadjuvant short-course radiotherapy followed by chemotherapy plus camrelizumab versus long-course chemoradiotherapy followed by chemotherapy for patients with locally advanced rectal cancer: A randomized, multicenter, open-label phase 3 trial (Union).

Abstract Poster

Authors

null

Zhenyu Lin

Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Zhenyu Lin , Peng Zhang , Zhiguo Hou , Kaixiong Tao , Tao Zhang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Local-Regional Disease

Clinical Trial Registration Number

NCT04928807

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS3638)

DOI

10.1200/JCO.2023.41.16_suppl.TPS3638

Abstract #

TPS3638

Poster Bd #

331a

Abstract Disclosures

Similar Posters

First Author: Jun Watanabe

First Author: Weiwei Xiao

First Author: Samuel J Klempner

First Author: Aiwen WU